Related Party Transactions |
6 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 | |||
| Related Party Transactions | |||
| Related Party Transactions |
Foresite Labs Services Agreement Foresite Labs, LLC (“Foresite Labs”) is an affiliate of Foresite Capital Management, a stockholder of the Company. In January 2021, the Company entered into a services agreement with Foresite Labs, which was amended and restated in August 2021 and in December 2023, and expires in December 2026, unless terminated earlier by the parties. Thereafter, on each anniversary of the effective date, the agreement will automatically renew for an additional one-year term, unless terminated earlier by the parties. Foresite Labs provides services to assist the Company in exploring specified immunology genetic targets. The Company recognized $0.4 million and $0.3 million as research and development expenses under the services agreement for the three months ended June 30, 2026 and 2025, respectively. The Company recognized $0.5 million as research and development expenses under the services agreement for each of the six months ended June 30, 2026 and 2025. There were no accrued expenses under the services agreement as of June 30, 2026 and December 31, 2025. |